LianBio’s mission is to catalyze the development and accelerate availability of paradigm-shifting medicines to patients in China and major Asian markets through partnerships that provide access to the best science-driven therapeutic discoveries.Learn More
We are focused on building out a pipeline based on disease relevance to our target markets and the ability to impact patients with transformative mechanisms and precision-based therapeutics. We select programs with a strong scientific basis and clinical data and collaborate with world-class partners across a diverse array of therapeutic areas.See All
There are over 290 million people in China with cardiovascular disease and more than 100 million with chronic kidney disease. Cardiorenal disease is the leading cause of death in China today.
5.5 people die from cancer every minute in China alone and every year there are more than 4.5 million new cases diagnosed.
Shanghai Office 16F, 5 Corporate Avenue No.150 Hubin Rd, Huangpu District Shanghai
New Jersey Office 103 Carnegie Center Drive Suite 309 Princeton, NJ 08540
Beijing Office Room 115, 3rd Floor, N3 Building, Taigu Li North District No. 11 Sanlitun Road, Chaoyang District Beijing
Guangzhou Office Room A17, 25 F Development Center 3 Linjiang Road，Zhujiang New Town，Tianhe Guangzhou